Nirvana Life Sciences Inc.

CNSX:NIRV Stok Raporu

Piyasa değeri: CA$3.6m

Nirvana Life Sciences Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Bruce Clark

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi6.9yrs
CEO sahipliği13.2%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi2.6yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Bruce Clark'un ücretlendirmesi Nirvana Life Sciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jan 31 2024n/an/a

-CA$1m

Oct 31 2023n/an/a

-CA$1m

Jul 31 2023n/an/a

-CA$2m

Apr 30 2023CA$180kCA$180k

-CA$1m

Jan 31 2023n/an/a

-CA$6m

Oct 31 2022n/an/a

-CA$6m

Jul 31 2022n/an/a

-CA$6m

Apr 30 2022CA$180kCA$180k

-CA$6m

Jan 31 2022n/an/a

-CA$991k

Oct 31 2021CA$180kCA$180k

-CA$959k

Apr 30 2021n/an/a

-CA$735k

Tazminat ve Piyasa: Insufficient data to establish whether Bruce's total compensation is reasonable compared to companies of similar size in the Canadian market.

Tazminat ve Kazançlar: Bruce's compensation has been consistent with company performance over the past year.


CEO

Bruce Clark (63 yo)

6.9yrs

Görev süresi

CA$180,000

Tazminat

Mr. Bruce Clark is Chief Executive Officer at Nirvana Life Sciences Inc. and serves as its Director since December 04, 2017. He is a principal of Broadwing Renewables Inc., Anyox Hydro Electric Corporation...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Bruce Clark
CEO & Director6.9yrsCA$180.00k13.18%
CA$ 476.7k
Patricia Storey
CFO & Director7.6yrsVeri yok0.77%
CA$ 27.8k
Sheldon Inwentash
Independent Director2yrsVeri yok3.11%
CA$ 112.5k
Jakson Inwentash
Independent Director2.5yrsVeri yok1.04%
CA$ 37.5k
Mark Marissen
Independent Director4.8yrsVeri yokVeri yok
Andrew Samann
Member of Advisory Board2.6yrsVeri yokVeri yok
Richard Monroe
Independent Director1.5yrsVeri yokVeri yok

2.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: NIRV's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.